Journal
/
/
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
JoVE 신문
의학
This content is Free Access.
JoVE 신문 의학
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
DOI:

06:15 min

October 27, 2014

Chapters

  • 00:05Title
  • 01:35Assembling the Tumor Treating Fields System
  • 02:49Applying the Transducer Arrays to the Scalp
  • 04:11Results: Patient Treated with Tumor Treating Field Therapy with Bevacizumab
  • 05:34Conclusion

Summary

자동 번역

A novel methodology that is employed for the treatment of recurrent glioblastomas is described. This treatment approach employs the application of alternating electric tumor treating fields (TTFields), known as TTF Therapy in combination with bevacizumab, a targeted agent that is currently FDA approved as monotherapy.

Related Videos

Read Article